Solid Biosciences LLC
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +700.0% | +249.6% | +80.3% | +38.9% | -24.4% | -18.8% | +7.2% | -4.9% | -176.3% | |
| – | +92.4% | +262.6% | +11.7% | +138.6% | -18.1% | +15.0% | -43.6% | +1.2% | +38.0% | +60.8% | |
| – | -343.1% | – | +48.3% | +138.4% | -18.3% | +16.0% | -44.0% | – | – | – | |
| – | +75.4% | +59.0% | -164.0% | – | +108.4% | -242.6% | – | – | – | -339.4% | |
| – | +0.0% | +480.6% | +241.7% | -43.6% | -79.5% | +42.5% | +135.4% | -49.8% | -56.8% | +76.3% | |
| – | -84.3% | – | -353.7% | – | -73.1% | -1,480.1% | – | -83.6% | -266.0% | +263.4% | |
| – | -50.0% | +2,224.6% | +65.4% | -56.0% | -66.7% | +599.7% | -46.2% | -100.0% | – | -67.1% | |
| – | +0.0% | +0.0% | +0.0% | – | – | – | – | -100.0% | – | +52.9% | |
| – | -93.4% | +2,153.7% | +70.6% | -56.0% | +122.4% | +4.9% | -44.6% | -95.8% | +3,821.7% | +58.8% | |
| – | -201.6% | – | -22.2% | -129.9% | – | -143.0% | – | -326.0% | – | -420.2% | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.